To determine whether METTL5 played a role in SEPHS2-mediated control of selenoproteins during MM, we measured protein levels of GPX4 and thioredoxin reductase 1 (TXNRD1) in control and METTL5-overexpressing MM cells. The gene discussed is GPX4; the disease is Miyoshi myopathy.